Melatonin Orifarm

Melatonin, the active ingredient in Melatonin Orifarm, is a melatonin receptor agonist presented as an oral tablet for oral use. It helps regulate the sleep‑wake cycle and is used to treat sleep onset insomnia, jet lag and other circadian rhythm sleep disorders in adults.

GNH USA supplies Melatonin Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable logistics for bulk and unit‑dose orders, including temperature‑controlled shipping where required.

Melatonin Orifarm acts on melatonin receptors to address disorders of the sleep‑wake cycle.

Sleep onset insomnia: facilitates faster sleep initiation in adults with difficulty falling asleep. Jet lag: reduces the time needed to adjust to new time zones after rapid travel. Circadian rhythm sleep disorders: helps synchronize abnormal internal clocks to a normal pattern.

Melatonin Orifarm may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild throbbing pain that usually resolves spontaneously. - Dizziness: transient light‑headed sensation, often occurring after the first dose. - Daytime sleepiness: feeling unusually drowsy during waking hours. - Nausea: mild stomach upset that typically subsides.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or angioedema requiring medical attention. - Severe hypersensitivity: anaphylactic symptoms such as swelling of the throat or difficulty breathing. - Mood changes: emergence of depression, irritability, or vivid dreams that may affect daily functioning.

Before initiating Melatonin Orifarm, consider the following precautions.

- Confirm diagnosis: ensure the sleep disorder is appropriately identified before initiating therapy. - Review concomitant CNS depressants: assess risk when used with alcohol, benzodiazepines or antihistamines. - Assess hepatic function: dose adjustment may be needed in patients with liver impairment. - Use caution in children: melatonin should only be prescribed for pediatric use when clearly indicated. - Monitor for allergic reactions: discontinue if rash, swelling or breathing difficulty occurs. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Melatonin Orifarm can interact with several medicines; awareness of the level of interaction helps guide safe use.

Major Interactions (Avoid): - CNS depressants (e.g., alcohol, benzodiazepines): may increase sedation and impair alertness. - Anticoagulants (e.g., warfarin): melatonin can enhance anticoagulant effect and raise bleeding risk. - Anticonvulsants (e.g., carbamazepine): may reduce melatonin plasma levels, decreasing efficacy.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): may alter melatonin metabolism, requiring observation. - Beta‑blockers: can blunt endogenous melatonin secretion, potentially affecting response. - Oral contraceptives: may increase circulating melatonin concentrations, necessitating monitoring.